A Four-Parameter Index of Marrow Dysplasia Has Predictive Value for Survival in Myelodysplastic Syndromes

References

• Anastasi J. Molecular cytogenetics and the myelodys-plastic syndromes. Leukemia Research 1996; 20: 559–62
   PubMed Web of Science ®Google Scholar
• Raza A, Gezer S, Mundle S, et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 1995; 86: 268–76
   PubMed Web of Science ®Google Scholar
• Rajapaksa R, Ginzton N, Rott L S, Greenberg P L. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood 1996; 88: 4275–87
   PubMed Web of Science ®Google Scholar
• Barosi G, Cazzola M, Morandi S, Stefanelli M, Perugini S. Estimation of ferrokinetic parameters by a mathematical model in patients with primary acquired sideroblastic anaemia. British Journal of Haematology 1978; 39: 409–23
   PubMed Web of Science ®Google Scholar
• Cazzola M, Barosi G, Berzuini C., et al. Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes. British Journal of Haematology 1982; 50: 55–62
   PubMed Web of Science ®Google Scholar
• May S J, Smith S A, Jacobs A, Williams A, Bailey-Wood R. The myelodysplastic syndrome : analysis of laboratory characteristics in relation to the FAB classification. British Journal of Haematology 1985; 59: 311–9
   PubMed Web of Science ®Google Scholar
• Brada S, de Wolf J, Hendriks D, Louwes H, Van den Berg F., Vellenga E. Characterization of the erythropoiesis in myelodysplasia by means of ferrokinetic studies, in vitro erythroid colony formation and soluble transferrin receptor. Leukemia 1998; 12: 340–5
   PubMed Web of Science ®Google Scholar
• Raskind W H, Tirumali N, Jacobson R, Singer J, Fialkow P J. Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood 1984; 63: 1318–23
   PubMed Web of Science ®Google Scholar
• Mufti G J. Chromosomal deletions in the myelodysplastic syndrome. Leukemia Research 1992; 16: 35–41
   PubMed Web of Science ®Google Scholar
• San Miguel J F, Hernandez J M, Gonzalez-Sarmiento R, et al. Acute leukemia after a primary myelodysplastic syndrome : immunophenotypic, genotypic, and clinical characteristics. Blood 1991; 78: 768–74
   PubMed Web of Science ®Google Scholar
• Greenberg P, Cox C., LeBeau M M, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079–88
   PubMed Web of Science ®Google Scholar
• Bennett J M, Catovsky D, Daniel M T, et al. Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology 1982; 51: 189–99
   PubMed Web of Science ®Google Scholar
• Coiffier B, Adeleine P, Viala J J, et al. Dysmyelopoie-tic syndromes. A search for prognostic factors. Cancer 1983; 52: 83–90
   PubMed Web of Science ®Google Scholar
• Varela B L, Chuang C., Woll J E, Bennett J M. Modifications in the classification of primary myelodysplastic syndromes : the addition of a scoring system. Hematological Oncology 1985; 3: 55–63
   PubMed Web of Science ®Google Scholar
• Kerkhofs H, Hermans J, Haak H L, Leeksma C. Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. British Journal of Haematology 1987; 65: 73–81
   PubMed Web of Science ®Google Scholar
• Economopoulos T, Stathakis N, Foudoulakis A, et al. Myelodysplastic syndromes: analysis of 131 cases according to the FAB classification. European Journal of Haematology 1987; 38: 338–44
   PubMed Web of Science ®Google Scholar
• Coiffier B, Adeleine P, Gentilhomme O, Felman P, Treille-Ritouet D, Bryon P A. Myelodysplastic syndromes. A multiparametric study of prognostic factors in 336 patients. Cancer 1987; 60: 3029–32
   PubMed Web of Science ®Google Scholar
• Mufti G J, Stevens J R, Oscier D G, Hamblin T J, Machin D. Myelodysplastic syndromes: a scoring system with prognostic significance. British Journal of Haematology 1985; 59: 425–33
   PubMed Web of Science ®Google Scholar
• Sanz G F, Sanz M A, Vallespi T, et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes : a multivariate analysis of prognostic factors in 370 patients. Blood 1989; 74: 395–408
   PubMed Web of Science ®Google Scholar
• Goasguen J E, Garand R, Bizet M, et al. Prognostic factors of myelodysplastic syndromes : a simplified 3-D scoring system. Leukemia Research 1990; 14: 255–62
   PubMed Web of Science ®Google Scholar
• Sanz G F, Sanz M A. Prognostic factors in myelodysplastic syndromes. Leukemia Research 1992; 16: 77–86
   PubMed Web of Science ®Google Scholar
• Second MIC Cooperative Study Group. Morphologic, immunologic, and cytogenetic (MIC) working classification of the acute myeloid leukemias. Cancer Genetics and Cytogenetics 1988; 30: 1–15
   PubMed Web of Science ®Google Scholar
• Yunis J J, Lobell M, Arnesen M A, et al. Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. British Journal of Haematology 1988; 68: 189–94
   PubMed Web of Science ®Google Scholar
• Suciu S, Kuse R, Weh H J, Hossfeld D K. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome. Cancer Genetics and Cytogenetics 1990; 44: 15–26
   PubMed Web of Science ®Google Scholar
• Toyama K, Ohyashiki K, Yoshida Y, et al. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes : a multicentric study in Japan. Leukemia 1993; 7: 499–508
   PubMed Web of Science ®Google Scholar
• Morel P, Hebbar M, Lai J L, et al. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system : a report on 408 cases. Leukemia 1993; 7: 1315–23
   PubMed Web of Science ®Google Scholar
• Jotterand M, Parlier V. Diagnostic and prognostic significance of cytogenetics in adult primary myelodysplastic syndromes. Leukemia and Lymphoma 1996; 23: 253–66
   PubMed Web of Science ®Google Scholar
• Fenaux P, Morel P, Lai J L. Cytogenetics of myelodysplastic syndromes. Seminars in Hematology 1996; 33: 127–38
   PubMed Web of Science ®Google Scholar
• Mufti G J. A guide to risk assessment in the primary myelodysplastic syndrome. Hematology and Oncology Clinics of North America 1992; 6: 587–606
   PubMed Web of Science ®Google Scholar
• Estey F., Keating M, Pierce S, Beran M. Application of the international scoring system for myelodysplasia to M. D. Anderson patients. Blood 1997; 90: 2843–4
   PubMed Web of Science ®Google Scholar
• Greenberg P, LeBeau M M, Fenaux P, et al. Application of the international scoring system for myelodysplasia to M.D. Anderson patients : response to Estey et al. Blood 1997; 90: 2844–5
   Web of Science ®Google Scholar
• Langenhuijsen M. Neutrophils with ring-shaped nuclei in myeloproliferative disease. British Journal of Haematology 1984; 58: 227–30
   PubMed Web of Science ®Google Scholar
• Kuriyama K, Tomonaga M, Matsuo T, Ginnai I, Ichimaru M. Diagnostic significance of detecting pseudo-Pel-ger-Huët anomalies and micromegakaryocytes in myelodysplastic syndrome. British Journal of Haematology 1986; 63: 665–9
   PubMed Web of Science ®Google Scholar
• Teerenhovi L, Lintula R, Ruutu T, Knuutila S. Correlation between bone marrow karyotype and the occurence of erythroblast micronuclei and nuclear budding in patients with myelodysplastic syndromes. European Journal of Haematology 1987; 39: 237–40
   PubMed Web of Science ®Google Scholar
• Felman P, Bryon P A, Gentilhomme O, et al. The syndrome of abnormal chromatin clumping in leucocytes : a myelodysplastic disorder with proliferative features?. British Journal of Haematology 1988; 70: 49–54
   PubMed Web of Science ®Google Scholar
• van der Weide M, Sizoo W, Krefft J, Langenhuijsen M M. Myelodysplastic syndromes : analysis of morphological features related to the FAB-classification. European Journal of Haematology 1988; 41: 58–61
   PubMed Web of Science ®Google Scholar
• Garcia S, Sanz M A, Amigo V, et al. Prognostic factors in chronic myelodysplastic syndromes : a multivariate analysis in 107 cases. American Journal of Hematology 1988; 27: 163–8
   PubMed Web of Science ®Google Scholar
• Hast R, Nilsson I, Widell S, Öst A. Diagnostic significance of dysplastic features of peripheral blood polymorphs in myelodysplastic syndromes. Leukemia Research 1989; 13: 173–8
   PubMed Web of Science ®Google Scholar
• Jaen A, Irriguible D, Milla F, et al. Abnormal chroma-tin clumping in leucocytes: a clue to a new subtype of myelodysplastic syndrome. European Journal of Haematology 1990; 45: 209–14
   PubMed Web of Science ®Google Scholar
• Goasguen J E, Bennett J M, Cox C., Hambley H, Mufti G, Flandrin G. Prognostic implication and characterization of the blast cell population in the myelodysplastic syndrome. Leukemia Research 1991; 15: 1159–65
   PubMed Web of Science ®Google Scholar
• Wong K F, Chan J. Are “dysplastic” and hypogranular megakaryocytes specific markers for myelodysplastic syndrome?. British Journal of Haematology 1991; 77: 509–14
   PubMed Web of Science ®Google Scholar
• Aul C., Gattermann N, Heyll A, Germing U, Derigs G, Schneider W. Primary myelodysplastic syndromes : analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 1992; 6: 52–9
   PubMed Web of Science ®Google Scholar
• Bartl R, Frisch B, Baumgart R. Morphologic classification of the myelodysplastic syndromes (MDS): combined utilization of bone marrow aspirates and trephine biopsies. Leukemia Research 1992; 16: 15–33
   PubMed Web of Science ®Google Scholar
• Widell S, Hellström-Lindberg F., Kock Y, Lindberg M, Öst A, Hast R. Peripheral blood neutrophil morphology reflects bone marrow dysplasia in myelodysplastic syndromes. American Journal of Hematology 1995; 49: 115–20
   PubMed Web of Science ®Google Scholar
• Mazzone A, Porta C., Fossati G, Gritti D, Mazzucchelli I, Ricevuti G. Granulocyte dysplasia and dysfunction, and CD11/CD18 defects in myelodysplastic syndromes. Leukemia and Lymphoma 1996; 23: 267–75
   PubMed Web of Science ®Google Scholar
• Kouides P A, Bennett J M. Morphology and classification of the myelodysplastic syndromes and their pathologic variants. Seminars in Hematology 1996; 33: 95–110
   PubMed Web of Science ®Google Scholar
• Kapff C T, Jandl J H. 1st edn. Blood: Alias and Sourcebook of Hematology. Little, Brown and Company, Boston 1981; 20
   Google Scholar
• ISCN (1995) An International System for Human Cytogenetic Nomenclature, F. Mitelman. Karger, BaselSwitzerland 1995
   Google Scholar
• Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960; 20: 37–46
   Web of Science ®Google Scholar
• Cox D. Regression models and life tables. Journal of the Royal Statistical Society 1972; 34: 187–220
   Google Scholar
• Flandrin G. Haematological cytology image bank and teletransmission for microscopic diagnosis. Archives d'Anat-omie et de Cytologie Pathologiques 1995; 43: 257–61
   PubMedGoogle Scholar